Publication | Closed Access
Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.
29
Citations
0
References
2003
Year
Using these doses and schedules, the GO regimen appears a safe therapy for patients with advanced urothelial cancer. Phase II studies are required to assess the possible role of this combination in advanced urothelial cancer.